HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kent E Wallner Selected Research

Isotopes

3/2007Long-term rectal function after permanent prostate brachytherapy.
1/2006The influence of isotope and prostate volume on urinary morbidity after prostate brachytherapy.
7/2005Monotherapeutic brachytherapy for clinically organ-confined prostate cancer.
6/2005Erectile function after prostate brachytherapy.
5/2005The impact of primary Gleason grade on biochemical outcome following brachytherapy for hormone-naive Gleason score 7 prostate cancer.
3/2005Brachytherapy-related dysuria.
1/2005Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.
1/2005The impact of radiation dose to the urethra on brachytherapy-related dysuria.
1/2005Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.
1/2004Effect of transurethral resection on urinary quality of life after permanent prostate brachytherapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kent E Wallner Research Topics

Disease

71Prostatic Neoplasms (Prostate Cancer)
09/2015 - 10/2002
22Neoplasms (Cancer)
09/2013 - 10/2002
12Hypertension (High Blood Pressure)
11/2009 - 01/2003
5Neoplasm Metastasis (Metastasis)
12/2013 - 10/2008
5Adenocarcinoma
01/2005 - 10/2002
4Erectile Dysfunction
01/2012 - 01/2003
4Carcinoma (Carcinomatosis)
07/2010 - 05/2003
4Dysuria
10/2007 - 03/2003
3Urethral Stricture
10/2017 - 07/2005
3Diabetes Mellitus
12/2012 - 01/2003
3Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
01/2006 - 08/2004
2Colorectal Neoplasms (Colorectal Cancer)
09/2012 - 09/2006
2Obesity
07/2011 - 12/2007
1Hemorrhage
10/2017
1Coronary Artery Disease (Coronary Atherosclerosis)
12/2012
1Cardiovascular Diseases (Cardiovascular Disease)
01/2010
1Overactive Urinary Bladder (Overactive Bladder)
03/2008
1Myocardial Infarction
10/2006
1Rectal Neoplasms (Rectal Cancer)
09/2006
1Polyps
09/2006
1Pathologic Constriction (Stenosis)
04/2006
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2003
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2003
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2003
1Hypertrophy
01/2003

Drug/Important Bio-Agent (IBA)

20AndrogensIBA
09/2013 - 01/2004
13Prostate-Specific Antigen (Semenogelase)IBA
07/2012 - 01/2003
13IsotopesIBA
03/2007 - 01/2003
10Hormones (Hormone)IBA
08/2010 - 10/2002
3Palladium-103IBA
09/2015 - 10/2002
3Testosterone (Sustanon)FDA Link
01/2012 - 07/2009
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
08/2006 - 12/2005
2Atorvastatin (Lipitor)FDA Link
08/2006 - 12/2005
2Iodine-125IBA
01/2005 - 10/2002
2Sildenafil Citrate (Viagra)FDA Link
05/2003 - 01/2003
1Indicators and Reagents (Reagents)IBA
05/2012
1thiaclopridIBA
06/2010
1trospium chloride (Ceris)FDA LinkGeneric
03/2008
1bicalutamide (Casodex)FDA LinkGeneric
07/2006
1Dutasteride (Avodart)FDA Link
07/2006
1prostatic acid phosphataseIBA
05/2005
1Tamsulosin (Flomax)FDA LinkGeneric
03/2005
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
05/2004

Therapy/Procedure

76Brachytherapy
10/2017 - 10/2002
27Radiotherapy
09/2015 - 10/2002
23Therapeutics
12/2013 - 01/2004
4Catheters
10/2017 - 08/2004
3Transurethral Resection of Prostate (TURP)
10/2017 - 01/2004
3Prostatectomy (Retropubic Prostatectomy)
02/2012 - 08/2008
2Aftercare (After-Treatment)
12/2013 - 09/2006
1Colostomy
09/2012
1Neoadjuvant Therapy
08/2008
1Urinary Catheters
10/2007